Milademetan
Milademetan Uses, Dosage, Side Effects, Food Interaction and all others data.
Milademetan is under investigation in clinical trial NCT02319369 (Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)).
Trade Name | Milademetan |
Generic | Milademetan |
Milademetan Other Names | Milademetan |
Type | |
Formula | C30H34Cl2FN5O4 |
Weight | Average: 618.53 Monoisotopic: 617.1971882 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Milademetan